chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling
Clinical narrative: Swollen upper lip; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Swollen upper lip) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     Concurrent medical conditions included Shellfish allergy (Allergic to crab, gave hives.). Concomitant products included HYDROCHLOROTHIAZIDE, LISINOPRIL, METFORMIN, BUPROPION and NABUMETONE for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced LIP SWELLING (Swollen upper lip). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, LIP SWELLING (Swollen upper lip) outcome was unknown.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthma, Chills, Erythema, Fatigue
Clinical narrative: asthma has increased a little; itching; the glands under arms and breasts are pink; joint pain; headache; chills; Low fever; the glands under arms and breasts are swollen; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ASTHMA (asthma has increased a little), PRURITUS (itching), ERYTHEMA (the glands under arms and breasts are pink), ARTHRALGIA (joint pain) and HEADACHE (headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Autoimmune disorder.   On 15-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced ASTHMA (asthma has increased a little), PRURITUS (itching), ERYTHEMA (the glands under arms and breasts are pink), ARTHRALGIA (joint pain), HEADACHE (headache), CHILLS (chills), PYREXIA (Low fever), LYMPHADENOPATHY (the glands under arms and breasts are swollen), NAUSEA (nausea) and FATIGUE (fatigue). At the time of the report, ASTHMA (asthma has increased a little), PRURITUS (itching), ERYTHEMA (the glands under arms and breasts are pink), ARTHRALGIA (joint pain), HEADACHE (headache), CHILLS (chills), PYREXIA (Low fever), LYMPHADENOPATHY (the glands under arms and breasts are swollen), NAUSEA (nausea) and FATIGUE (fatigue) outcome was unknown.            No relevant concomitant medications reported. Treatment medication was not provided by the reporter.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Nausea, Pruritus, Pyrexia
Clinical narrative: asthma has increased a little; itching; the glands under arms and breasts are pink; joint pain; headache; chills; Low fever; the glands under arms and breasts are swollen; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ASTHMA (asthma has increased a little), PRURITUS (itching), ERYTHEMA (the glands under arms and breasts are pink), ARTHRALGIA (joint pain) and HEADACHE (headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Autoimmune disorder.   On 15-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced ASTHMA (asthma has increased a little), PRURITUS (itching), ERYTHEMA (the glands under arms and breasts are pink), ARTHRALGIA (joint pain), HEADACHE (headache), CHILLS (chills), PYREXIA (Low fever), LYMPHADENOPATHY (the glands under arms and breasts are swollen), NAUSEA (nausea) and FATIGUE (fatigue). At the time of the report, ASTHMA (asthma has increased a little), PRURITUS (itching), ERYTHEMA (the glands under arms and breasts are pink), ARTHRALGIA (joint pain), HEADACHE (headache), CHILLS (chills), PYREXIA (Low fever), LYMPHADENOPATHY (the glands under arms and breasts are swollen), NAUSEA (nausea) and FATIGUE (fatigue) outcome was unknown.            No relevant concomitant medications reported. Treatment medication was not provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Pain in extremity, X-ray
Clinical narrative: Pain in right leg; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Pain in right leg) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Pain in right leg). At the time of the report, PAIN IN EXTREMITY (Pain in right leg) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, X-ray: normal (normal) normal. On 07-Mar-2021, Blood test: normal (normal) normal. On 07-Mar-2021, X-ray: normal (normal) Normal.         The patient was hospitalized twice for less than 24 hours. No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash erythematous, Vaccination site reaction
Clinical narrative: Covid arm; a red rash; arm was itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid arm), PRURITUS (arm was itchy) and RASH ERYTHEMATOUS (a red rash) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (allergic to Augmentin.), Drug allergy (allergic to  clindamycin.), Sulfonamide allergy and Drug allergy (allergic to Glutamine powder.).    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced PRURITUS (arm was itchy). On 17-Mar-2021, the patient experienced VACCINATION SITE REACTION (Covid arm) and RASH ERYTHEMATOUS (a red rash). At the time of the report, VACCINATION SITE REACTION (Covid arm), PRURITUS (arm was itchy) and RASH ERYTHEMATOUS (a red rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided by the reporter. No treatment medication was provided by the reporter.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: white rash on arms extending to the shoulders; This spontaneous case was reported by a health care professional and describes the occurrence of RASH (white rash on arms extending to the shoulders) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (white rash on arms extending to the shoulders). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, RASH (white rash on arms extending to the shoulders) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Skin irritation, Vaccination site rash
Clinical narrative: feels like they're itching all over the body; irritation; rash in the arm where the shot was given; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (feels like they're itching all over the body), SKIN IRRITATION (irritation) and VACCINATION SITE RASH (rash in the arm where the shot was given) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE RASH (rash in the arm where the shot was given). On 17-Mar-2021, the patient experienced PRURITUS (feels like they're itching all over the body) and SKIN IRRITATION (irritation). At the time of the report, PRURITUS (feels like they're itching all over the body), SKIN IRRITATION (irritation) and VACCINATION SITE RASH (rash in the arm where the shot was given) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, SARS-CoV-2 test
Clinical narrative: fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and HEADACHE (headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030AZ1A) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer and Rheumatoid arthritis. Concomitant products included LETROZOLE for Cancer, LEVOTHYROXINE and VITAMIN D NOS for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was provided by the reporter.   This case was linked to MOD-2021-047858 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pain, Vaccination site swelling
Clinical narrative: hardness at the injection site; pain at the injection site; swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (hardness at the injection site), VACCINATION SITE PAIN (pain at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INDURATION (hardness at the injection site), VACCINATION SITE PAIN (pain at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site). At the time of the report, VACCINATION SITE INDURATION (hardness at the injection site), VACCINATION SITE PAIN (pain at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.    Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Needle separated from syringe; Medicine ran down her arm and dripped onto her pants leg; This spontaneous case was reported by an other health care professional and describes the occurrence of DEVICE CONNECTION ISSUE (Needle separated from syringe) and UNDERDOSE (Medicine ran down her arm and dripped onto her pants leg) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced DEVICE CONNECTION ISSUE (Needle separated from syringe) and UNDERDOSE (Medicine ran down her arm and dripped onto her pants leg). On 16-Mar-2021, DEVICE CONNECTION ISSUE (Needle separated from syringe) and UNDERDOSE (Medicine ran down her arm and dripped onto her pants leg) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient received a second primary dose in advice from the primary care physician as the first primary dose was suspected partial dose. No adverse event reported after the second primary dose. No concomitant medication details was reported by the reporter. No treatment medication details was reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Additional information received on 12-MAY-2021, updated second primary dose details.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pregnancy
Clinical narrative: Sore arm; Pregnant patient received Moderna vaccine; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PREGNANCY (Pregnant patient received Moderna vaccine) and PAIN IN EXTREMITY (Sore arm) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 02-Aug-2021. On 17-Mar-2021, the patient experienced PREGNANCY (Pregnant patient received Moderna vaccine). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PREGNANCY (Pregnant patient received Moderna vaccine) and PAIN IN EXTREMITY (Sore arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Treatment medications were provided
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Ear swelling, Swelling face, Vaccination site pain
Clinical narrative: Swelling both cheeks; Swelling around ear; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Swelling both cheeks), EAR SWELLING (Swelling around ear) and VACCINATION SITE PAIN (Pain at the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included Acid reflux (esophageal) (Stomach reflux). Concurrent medical conditions included Penicillin allergy.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced SWELLING FACE (Swelling both cheeks), EAR SWELLING (Swelling around ear) and VACCINATION SITE PAIN (Pain at the injection site). At the time of the report, SWELLING FACE (Swelling both cheeks), EAR SWELLING (Swelling around ear) and VACCINATION SITE PAIN (Pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. No treatment information provided.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: Was not feeling good; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Was not feeling good) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Cholesterol.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Was not feeling good). At the time of the report, MALAISE (Was not feeling good) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications included, medications for asthma and cholesterol were reported.   Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-048019 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 17-Mar-2021: Follow-up information received on 24-MAY 2021 contains no new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-048019:
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Redness from shoulder to elbow; Itchiness from shoulder to elbow; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (Redness from shoulder to elbow) and PRURITUS (Itchiness from shoulder to elbow) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 030A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Feb-2021, the patient experienced ERYTHEMA (Redness from shoulder to elbow) and PRURITUS (Itchiness from shoulder to elbow). On 17-Feb-2021, PRURITUS (Itchiness from shoulder to elbow) had resolved. On 21-Feb-2021, ERYTHEMA (Redness from shoulder to elbow) had resolved.            Concomitant product use was not provided by the reporter. Treatment medication was not provided by the reporter.   This case was linked to MOD-2021-061333 (Patient Link).
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash, Swelling
Clinical narrative: Redness; Itching ocassionally; Faith rash; Swollen, mushy; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swollen, mushy), ERYTHEMA (Redness), PRURITUS (Itching ocassionally) and RASH (Faith rash) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 007M20A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included LEVOTHYROXINE SODIUM (LEVOXYL) for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SWELLING (Swollen, mushy). On 14-Mar-2021, the patient experienced ERYTHEMA (Redness), PRURITUS (Itching ocassionally) and RASH (Faith rash). At the time of the report, SWELLING (Swollen, mushy), ERYTHEMA (Redness), PRURITUS (Itching ocassionally) and RASH (Faith rash) outcome was unknown.            No treatment information was provided.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (sore) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (sore). At the time of the report, PAIN (sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. The treatment information was unknown.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Palpitations
Clinical narrative: Problems breathing/ felt like she was gasping for air for a few minutes; Heart was racing; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Problems breathing/ felt like she was gasping for air for a few minutes), PALPITATIONS (Heart was racing) and CHILLS (Chills) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006MZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced DYSPNOEA (Problems breathing/ felt like she was gasping for air for a few minutes), PALPITATIONS (Heart was racing) and CHILLS (Chills). At the time of the report, DYSPNOEA (Problems breathing/ felt like she was gasping for air for a few minutes), PALPITATIONS (Heart was racing) and CHILLS (Chills) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. The  patient had problems breathing and had to sit up.  She felt like she was gasping for air for a few minutes. The patient was batter at the time of reporting.  The patient did not take any medications.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vomiting
Clinical narrative: Headache; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and VOMITING (Vomiting) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced HEADACHE (Headache) and VOMITING (Vomiting). At the time of the report, HEADACHE (Headache) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable No concomitant medications were reported No treatment drugs were reported
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Face swelling; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Face swelling) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced SWELLING FACE (Face swelling). At the time of the report, SWELLING FACE (Face swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reportedly, on 17-Feb-2021, the patient used a facial cream and had a slight reaction on her face. No relevant concomitant medications were reported. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Oxygen saturation
Clinical narrative: Fatigue; Chills; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), CHILLS (Chills) and HEADACHE (Headaches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue), CHILLS (Chills) and HEADACHE (Headaches). At the time of the report, FATIGUE (Fatigue), CHILLS (Chills) and HEADACHE (Headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Oxygen saturation: low (Low) Low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Allids to treat the headaches.  The patient was tested for IgG antibodies after the first dose of the vaccine and did not have any.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: real high fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (real high fever) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PYREXIA (real high fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (real high fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Received a dose of the Moderna COVID19 vaccine from a vial that went through a temperature; A spontaneous report was received from a pharmacist concerning 83 year old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and reported events like patient received a dose of the Moderna COVID-19 vaccine from a vial that went through a temperature excursion/improper storage of the product use.  The patient's medical history was not provided. No concomitant medications were reported.  On an unknown date, prior to the onset of the events, the patient received their first of the two planned doses of mRNA-1273(lot/batch: 027L20A) intramuscularly in the anatomical position for prophylaxis of COVID-19 infection.  On an unknown date, patient received a dose of the Moderna COVID-19 vaccine from a vial that went through a temperature excursion. Laboratory details were not reported.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the event of patient received a dose of the Moderna COVID-19 vaccine from a vial that went through a temperature excursion was considered as resolved.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Decreased appetite, Dizziness, Headache, Nausea
Clinical narrative: lack of appetite; Dizziness; Nausea. Felt like throwing up but nothing came up; terrible headache; Temperature of 102F; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (lack of appetite), DIZZINESS (Dizziness), NAUSEA (Nausea. Felt like throwing up but nothing came up), HEADACHE (terrible headache) and PYREXIA (Temperature of 102F) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 013M207) for COVID-19 vaccination.     Concomitant products included AMLODIPINE, FAMOTIDINE and CALCIUM, COLECALCIFEROL (CALCIUM & VITAMIN D [CALCIUM;COLECALCIFEROL]) for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced DECREASED APPETITE (lack of appetite), DIZZINESS (Dizziness), NAUSEA (Nausea. Felt like throwing up but nothing came up), HEADACHE (terrible headache) and PYREXIA (Temperature of 102F). The patient was treated with CAMPHOR, EUCALYPTUS GLOBULUS OIL, MENTHOL, SYZYGIUM AROMATICUM OIL (TIGER BALM [CAMPHOR;EUCALYPTUS GLOBULUS OIL;MENTHOL;SYZYGIUM AROMATICUM OIL]) for Headache, at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (lack of appetite), DIZZINESS (Dizziness), NAUSEA (Nausea. Felt like throwing up but nothing came up), HEADACHE (terrible headache) and PYREXIA (Temperature of 102F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102f (High) 102F.         Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-048000 (Patient Link).
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: lack of appetite; Dizziness; Nausea. Felt like throwing up but nothing came up; terrible headache; Temperature of 102F; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (lack of appetite), DIZZINESS (Dizziness), NAUSEA (Nausea. Felt like throwing up but nothing came up), HEADACHE (terrible headache) and PYREXIA (Temperature of 102F) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 013M207) for COVID-19 vaccination.     Concomitant products included AMLODIPINE, FAMOTIDINE and CALCIUM, COLECALCIFEROL (CALCIUM & VITAMIN D [CALCIUM;COLECALCIFEROL]) for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced DECREASED APPETITE (lack of appetite), DIZZINESS (Dizziness), NAUSEA (Nausea. Felt like throwing up but nothing came up), HEADACHE (terrible headache) and PYREXIA (Temperature of 102F). The patient was treated with CAMPHOR, EUCALYPTUS GLOBULUS OIL, MENTHOL, SYZYGIUM AROMATICUM OIL (TIGER BALM [CAMPHOR;EUCALYPTUS GLOBULUS OIL;MENTHOL;SYZYGIUM AROMATICUM OIL]) for Headache, at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (lack of appetite), DIZZINESS (Dizziness), NAUSEA (Nausea. Felt like throwing up but nothing came up), HEADACHE (terrible headache) and PYREXIA (Temperature of 102F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102f (High) 102F.         Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-048000 (Patient Link).
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chest discomfort, Head discomfort
Clinical narrative: Extreme discomfort in chest; Burning; Heavy feeling in her head; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Extreme discomfort in chest), BURNING SENSATION (Burning) and HEAD DISCOMFORT (Heavy feeling in her head) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included Acid reflux (esophageal) and Barrett's esophagus. Concomitant products included VALSARTAN, SIMVASTATIN and LABETALOL for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced CHEST DISCOMFORT (Extreme discomfort in chest), BURNING SENSATION (Burning) and HEAD DISCOMFORT (Heavy feeling in her head). The patient was treated with CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) for Burning esophagus, at an unspecified dose and frequency and ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) for Burning esophagus, at an unspecified dose and frequency. At the time of the report, CHEST DISCOMFORT (Extreme discomfort in chest), BURNING SENSATION (Burning) and HEAD DISCOMFORT (Heavy feeling in her head) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       extreme discomfort in chest which is not intolerable but noticeable and a heavy feeling in her head.  She wanted to know what to expect with 2nd dose.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chest discomfort, Head discomfort
Clinical narrative: Burning; Extreme discomfort in chest; A heavy feeling in her head; A spontaneous report was received from a consumer concerning a 81-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the event(s) burning, extreme discomfort in chest and a heavy feeling in her head.   The patient's medical history Barrett's oesophagus and a severe acid reflux. Concomitant medication included valsartan, simvastatin and labetalol.  On 11 Mar 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 038A21A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.     On 11 Mar 2021, the patient reported that she is having burining, extreme discomfort in chest which is not intolerable but noticeable and a heavy feeling in her head.  Treatment details included tums and nexium OTC.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the event(s) burning, extreme discomfort in chest and heavy feeling in her head were unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: round patch that was itchy; red; warm; knot in that area; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (knot in that area ), VACCINATION SITE PRURITUS (round patch that was itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE WARMTH (warm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event history.).    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE INDURATION (knot in that area ). On 13-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (round patch that was itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE WARMTH (warm). At the time of the report, VACCINATION SITE INDURATION (knot in that area ), VACCINATION SITE PRURITUS (round patch that was itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE WARMTH (warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment of the events were not reported.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rash
Clinical narrative: Pain/ whenever she wears clothes it bothers her skin; Full body rash/ rash was all over body, in arm her arms and in her arm pit; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN (Pain/ whenever she wears clothes it bothers her skin) and RASH (Full body rash/ rash was all over body, in arm her arms and in her arm pit) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included TRIAMCINOLONE and PREDNISONE for an unknown indication.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Pain/ whenever she wears clothes it bothers her skin) and RASH (Full body rash/ rash was all over body, in arm her arms and in her arm pit). At the time of the report, PAIN (Pain/ whenever she wears clothes it bothers her skin) and RASH (Full body rash/ rash was all over body, in arm her arms and in her arm pit) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reportedly, after about 17-18 days of receiving first dose, the patient had a reaction all over her body. She thought that was may be from her laundry detergent. The rash was all over body, in her arms and in her arm pit. Whenever she was wearing clothes it was bothering her skin. No treatment information was provided.   This case was linked to MOD-2021-048012 (Patient Link).
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Migraine, Myalgia, Pain in extremity
Clinical narrative: migraine; arm pain; Muscle pain; right arm of injection hurt; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine), PAIN IN EXTREMITY (arm pain), MYALGIA (Muscle pain) and INJECTION SITE PAIN (right arm of injection hurt) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 02SO20A and 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Allergy. Concomitant products included PROLIFE for Asthma, ZINC and VITAMIN B COMPLEX for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MIGRAINE (migraine), PAIN IN EXTREMITY (arm pain), MYALGIA (Muscle pain) and INJECTION SITE PAIN (right arm of injection hurt). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, MIGRAINE (migraine), PAIN IN EXTREMITY (arm pain), MYALGIA (Muscle pain) and INJECTION SITE PAIN (right arm of injection hurt) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to MOD-2021-030576 (Patient Link).
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Very itchy; Skin was pink; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Very itchy) and VACCINATION SITE ERYTHEMA (Skin was pink) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced VACCINATION SITE PRURITUS (Very itchy) and VACCINATION SITE ERYTHEMA (Skin was pink). At the time of the report, VACCINATION SITE PRURITUS (Very itchy) and VACCINATION SITE ERYTHEMA (Skin was pink) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient took the regular medication Tylenol as treatment as she always takes.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Bone pain, Chills, Hyperhidrosis, Malaise, Nausea
Clinical narrative: Feeling really bottom down; chills; Nauseous; Every bone is aching so bad; Sweating; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Every bone is aching so bad), HYPERHIDROSIS (Sweating), MALAISE (Feeling really bottom down), CHILLS (chills) and NAUSEA (Nauseous) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced BONE PAIN (Every bone is aching so bad), HYPERHIDROSIS (Sweating), CHILLS (chills) and NAUSEA (Nauseous). On an unknown date, the patient experienced MALAISE (Feeling really bottom down). The patient was treated with CAMPHOR, MENTHOL, METHYL SALICYLATE (BENGAY [CAMPHOR;MENTHOL;METHYL SALICYLATE]) at an unspecified dose and frequency. At the time of the report, BONE PAIN (Every bone is aching so bad), HYPERHIDROSIS (Sweating), MALAISE (Feeling really bottom down), CHILLS (chills) and NAUSEA (Nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was not taking any other concomitant medications.  Reportedly, the symptoms started on the night of 15-Mar-2021. The patient rubbed Bengay to treat symptoms.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: Muscle pain, it's not that bad; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle pain, it's not that bad) and HEADACHE (Headache) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced MYALGIA (Muscle pain, it's not that bad) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, MYALGIA (Muscle pain, it's not that bad) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that Concomitant products included  were asthma medicines (several medicals).  It was reported that patient had headache after 15 minutes after receiving the medicine.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Additional information received included denial of consent for further followup
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Exercise tolerance decreased, Pain in extremity
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (pain in arms, legs and hips), exercise tolerance decreased (usually walks about 4 miles but was only able to walk 2 blocks after received the vaccine) and arthralgia, (pain in arms, legs and hips) in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. On an unknown date, patient experienced pain in extremity (pain in arms, legs and hips), exercise tolerance decreased (usually walks about 4 miles but was only able to walk 2 blocks after received the vaccine) and arthralgia (pain in arms, legs and hips). At the time of the report, pain in extremity (pain in arms, legs and hips), exercise tolerance decreased (usually walks about 4 miles but was only able to walk 2 blocks after the vaccination) and arthralgia (pain in arms, legs and hips) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications or treatment information provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.   On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) outcome was unknown.            No treatment information was provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Palpitations
Clinical narrative: Felt palpitations; Blood pressure started to rise 180 over 107; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Felt palpitations) and BLOOD PRESSURE INCREASED (Blood pressure started to rise 180 over 107) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Sleep disorder NOS. Concomitant products included CARVEDILOL for Blood pressure high, HYDROXYZINE HCL for Sleep disorder NOS, ATORVASTATIN, CALCIUM CARBONATE (OS CAL [CALCIUM CARBONATE]), VITAMIN D3 and ASCORBIC ACID, CALCIUM, MINERALS NOS, RETINOL, TOCOPHERYL ACETATE, VITAMIN B NOS, VITAMINS NOS, ZINC (CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS NOS;ZINC]) for an unknown indication.    On 16-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PALPITATIONS (Felt palpitations). 16-Mar-2021, the patient experienced BLOOD PRESSURE INCREASED (Blood pressure started to rise 180 over 107). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PALPITATIONS (Felt palpitations) and BLOOD PRESSURE INCREASED (Blood pressure started to rise 180 over 107) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, Blood pressure measurement: 180 over 107 (Inconclusive) started to rise.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reportedly, two hours after the vaccination, patient's blood pressure started to rise 180 over 107. Then she took a deep breath, and it went down a little but then went back up again. She took paracetamol and in the evening she took her blood pressure medicine.